The effect of local application of melatonin gel on the healing of periodontal osseous defects in experimentally induced diabetes in rabbits

Bostrom, 1998, Clinical expression of TNF-alpha in smoking-associated periodontal disease, J Clin Periodontol, 25, 767, 10.1111/j.1600-051X.1998.tb02368.x Tani-Ishii, 1999, Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha, J Dent Res, 78, 1617, 10.1177/00220345990780100601 Cochran, 2008, Inflammation and bone loss in periodontal disease, J Periodontol, 79, 1569, 10.1902/jop.2008.080233 Walsh, 2006, Osteoimmunology: interplay between the immune system and bone metabolism, Annu Rev Immunol, 24, 33, 10.1146/annurev.immunol.24.021605.090646 Takayanagi, 2007, Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems, Nat Rev Immunol, 7, 292, 10.1038/nri2062 Graves, 2008, Cytokines that promote periodontal tissue destruction, J Periodontol, 79, 1585, 10.1902/jop.2008.080183 Lee, 2008, Osteoimmunology: cytokines and skeletal system, BMB Rep, 41, 495, 10.5483/BMBRep.2008.41.7.495 Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3 Abu-Amer, 2001, IL-4 abrogates osteoclastogenesis throught STAT5-dependent inhibition of NF-kappaB, J Clin Invest, 107, 1375, 10.1172/JCI10530 Srivastava, 2003, Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells, J Biol Chem, 278, 46171, 10.1074/jbc.M308545200 Yasuda, 1998, Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro, Endocrinology, 139, 1329, 10.1210/endo.139.3.5837 Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL, Proc Natl Acad Sci U S A, 95, 3597, 10.1073/pnas.95.7.3597 Quinn, 2000, Fibroblastic stromalcells express receptor activator of NF-kappa B ligand and support osteoclast differentiation, J Bone Miner Res, 15, 1459, 10.1359/jbmr.2000.15.8.1459 Takayanagi, 2000, Involvement of receptor activator of nuclear factor kappa B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis, Arthritis Rheum, 43, 259, 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W Tsukii, 1998, Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone, Biochem Biophys Res Commun, 246, 337, 10.1006/bbrc.1998.8610 Khosla, 2001, Minireview: the OPG/RANKL/RANK system, Endocrinology, 142, 5050, 10.1210/endo.142.12.8536 Inoue, 1997, The effect of leukocyte function of streptozotocin-induced diabetes in naturally occuring gingivitis rat, J Osaka Dent Univ, 31, 47 Ozsoy, 2004, The investigation of the ultrastructural neutrophil changes in alloxan-induced diabetes in rats: response to a chemotactic challenge, Cell Biochem Funct, 22, 81, 10.1002/cbf.1059 Esposito, 2002, Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress, Circulation, 106, 2067, 10.1161/01.CIR.0000034509.14906.AE Gamonal, 2001, Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry, J Periodontol, 72, 517, 10.1902/jop.2001.72.4.517 Graves, 2006, Diabetes-enhanced inflammation and apoptosis e Impact on periodontal pathology, J Dent Res, 85, 15, 10.1177/154405910608500103 Mealey, 2006, Diabetes mellitus and periodontal diseases, J Periodontol, 77, 1289, 10.1902/jop.2006.050459 Brownlee, 1992, Glycation products and pathogenesis of diabetic complications, Diabetes Care, 15, 1835, 10.2337/diacare.15.12.1835 Li, 1996, Prevention of cardiovascular and renal pathology of aging by advanced glycation inhibitor aminoguanidine, Proc Natl Acad Sci, 93, 3902, 10.1073/pnas.93.9.3902 Norton, 1996, Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats, Circulation, 93, 1905, 10.1161/01.CIR.93.10.1905 Soulis, 1996, Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment, Kidney Int, 50, 627, 10.1038/ki.1996.358 Matsumoto, 1997, Imunochemical evidence for increased formation of advanced glycation endproducts and inhibition by aminoguanidine in diabetic rats lenses, Biochem Biophys Res Commun, 241, 352, 10.1006/bbrc.1997.7744 Reiter, 1991, Pineal melatonin: cell biology of its synthesis and of its physiological interactions, Endocr Rev, 12, 151, 10.1210/edrv-12-2-151 Reiter, 2001, Escames, G, Carazo A, Leon. Melatonin: mechanics and actions as an antioxidant, Curr Top Biophys, 24, 171 Tan, 2002, Chemical and physical properties and potential mechanisms: melationin as broad spectrum antioxidant and free radical scavenger, Curr Top Med Chem, 2, 181, 10.2174/1568026023394443 Allerga, 2003, The chemistry of melatonin’s interaction with reactive species, J Pineal Res, 34, 1, 10.1034/j.1600-079X.2003.02112.x Garcia-Maurino, 1997, Melatonin enhances IL-2, IL-6 and IFN-gamma production by human circulating CD4þ cells: a possible nuclear receptor-mediated mechanism involving T-helper type 1 lymphocytes and monocytes, J Immunol, 159, 574, 10.4049/jimmunol.159.2.574 Guerrero, 2002, Melatonin-immune system realtionship, Curr Top Med Chem, 2, 167, 10.2174/1568026023394335 Reiter, 1995, A review of the evidence supporting melatonin’s role as an antioxidant, J Pineal Res, 18, 1, 10.1111/j.1600-079X.1995.tb00133.x Crespo, 1999, Melatonin inhibits expression of the inducible NO-synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats, FASEB J, 13, 1537, 10.1096/fasebj.13.12.1537 Tan, 2000, Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation, Free Radic Biol Med, 29, 1177, 10.1016/S0891-5849(00)00435-4 Tan, 2000, Significance of melatonin in antioxidative defense system: reactions and products, Biol Signals Recept, 9, 137, 10.1159/000014635 Cutando, 2003, Relationship between salivary melatonin levels and periodontal status in diabetic patients, J Pineal Res, 35, 239, 10.1034/j.1600-079X.2003.00075.x Al-Tayib, 2005, Effects of streptozotocin on the molybdenum hydroxylases activities of the rabbits and guinea pigs, J Saud Univ, 18, 64 Kopman, 2005, Modulating the effect of diabetes on osseointegration with aminoguanidine and doxycycline, J Periodontol, 76, 614, 10.1902/jop.2005.76.4.614 El-Feshawy, 2008 El-Kholy, 2006 Duarte, 2007, Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis, Oral Dis, 13, 594, 10.1111/j.1601-0825.2006.01348.x Acuna, 2002, Melatonin, mitochondrial homeostasis and mitochondrial-related diseases, Curr Top Med Chem, 2, 133, 10.2174/1568026023394344 Cardinali, 2003, Melatonin effects on bone: experimental facts and clinical perspectives, J Pineal Res, 34, 81, 10.1034/j.1600-079X.2003.00028.x Leon, 2005, Melatonin mitigates mitochondrial malfunction, J Pineal Res, 38, 1, 10.1111/j.1600-079X.2004.00181.x Cutando, 2007, Local application of melatonin into alveolar sockets of beagle dogs reduces tooth removal-induced oxidative stress, J Periodontol, 78, 576, 10.1902/jop.2007.060244 Satomura, 2007, Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo, J Pineal Res, 42, 231, 10.1111/j.1600-079X.2006.00410.x Hein, 2006, Glycation end products in osteoporosis-is there a pathophysiologic importance?, Clin Chim Acta, 371, 32, 10.1016/j.cca.2006.03.017 Lalla, 2000, Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes associated periodontitis, Periodontol 2000, 23, 50, 10.1034/j.1600-0757.2000.2230104.x Lalla, 2000, Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice, J Clin Invest, 105, 1117, 10.1172/JCI8942 Yoshida, 2009, Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on s RANKL induced osteoclastogenesis, J Cell Biochem, 107, 917, 10.1002/jcb.22192 Deeqa, 2005, G(-) Anaerobe sereactive CD4 T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice, Diabetes, 54, 1477, 10.2337/diabetes.54.5.1477 Gyurko, 2006, Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice, J Immunol, 177, 7250, 10.4049/jimmunol.177.10.7250 Liu, 2003, Expression of RANKL and OPG mRNA in periodontal disease. Possible involvement in bone destruction, J Mol Med, 11, 17 Santos, 2010, Receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and wellcontrolled type 2 diabetes, J Periodontol, 81, 1455, 10.1902/jop.2010.100125 Hsu, 1999, Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand, Proc Natl Acad Sci U S A, 96, 3540, 10.1073/pnas.96.7.3540 De la Rocha, 2007, Structural basis of the anti-infiammatory activity of melatonin, Arzneimittelforschung, 57, 782 Nagasawa, 2000, Roles of receptor activators of nuclear factor e kB ligand (RANKL) and osteoprotegerin in periodontal health and disease, Periodontol, 2007, 65 Nakade, 1999, Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro, J Pineal Res, 27, 106, 10.1111/j.1600-079X.1999.tb00603.x Carrillo-Vico, 2005, A review of the multiple actions of melatonin on the immune system, Endocrine, 27, 189, 10.1385/ENDO:27:2:189 Koyama, 2002, Melatonin at pharmacological doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation, J Bone Miner Res, 17, 1219, 10.1359/jbmr.2002.17.7.1219 Lacey, 2000, Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo, Am J Pathol, 157, 435, 10.1016/S0002-9440(10)64556-7 O'Brien, 2000, Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria, Biochem Biophys Res Commun, 274, 281, 10.1006/bbrc.2000.3129 Rauner, 2007, Osteoimmunology, Int Arch Allergy Immunol, 143, 31, 10.1159/000098223 Winiarska, 2006, Melatonin attenuates diabetes-induced oxidative stress in rabbits, J Pineal Res, 40, 168, 10.1111/j.1600-079X.2005.00295.x Roth, 1999, Melatonin promotes osteoblast differentiation and bone formation, J Biol Chem, 274, 22041, 10.1074/jbc.274.31.22041 Radio, 2006, Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade, J Pineal Res, 40, 332, 10.1111/j.1600-079X.2006.00318.x Cutando, 2008, Melatonin stimulates osteointegration of dental implants, J Pineal Res, 45, 174, 10.1111/j.1600-079X.2008.00573.x